Abstract
After nearly two decades of development, Lab-on-a-Chip has finally found success in Point-of-Care (POC) diagnostics, and to a lesser extent, life science research. But its real future lies in the combination of DNA detection and rapid response times for clinical diagnostics, with a particular focus on infectious disease and cancer detection.
This report takes a look at the continually evolving lab-on-a-chip sector, including the companies developing these devices and the markets theyre pursuing. Forecasts of both unit shipments and revenues are provided through 2008.
View Cart
